Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: GlobalData
Provider: Directors Deals Ltd.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Jazz Pharmaceuticals PLC gives FY 2014 guidance in line with analysts' estimates

Tuesday, 25 Feb 2014 04:05pm EST 

Jazz Pharmaceuticals PLC:Expects fiscal 2014 revenues of $1.100-$1.160 bln.Expects fiscal 2014 GAAP net income per diluted share of $2.31-$2.84.Expects fiscal 2014 non-GAAP adjusted net income per diluted share of $8.00-$8.25.Fiscal 2014 revenue of $1.084 bln and EPS of $8.07 - Thomson Reuters I/B/E/S. 

Company Quote

1.83 +1.12%
24 Dec 2014